March 15, 2013 | BGI has successfully completed its tender offer for all outstanding shares of Complete Genomics, the Chinese firm said today. BGI's subsidiary Beta Acquisition will effect a "short-form" merger under Delaware law, BGI said, transforming Complete Genomics into a wholly owned BGI subsidiary without a meeting of the company's shareholder. GEN